Sandra Zinkel Archive — Page 1 of 1

Five women stand together in a laboratory, with shelves of equipment and a window behind them.
January 31, 2019

Cell death pathway implicated in bone marrow failure

Vanderbilt investigators have linked a specific form of programmed cell death to myelodysplastic syndrome, a type of bone marrow failure.

By Leigh MacMillan
October 11, 2018

Novel genetic study sheds new light on risk of heart attack

Loss of a protein that regulates mitochondrial function can greatly increase the risk of myocardial infarction (heart attack), Vanderbilt scientists reported Oct. 3 in the journal eLife.

By Bill Snyder
3D rendering of numerous red blood cells flowing through the interior of a blood vessel.
August 22, 2013

VU investigators land ‘bridge grants’ from hematology society

Utpal Davé, M.D., and Sandra Zinkel, M.D., Ph.D., have each received one-year, $100,000 “bridge grants” from the American Society of Hematology (ASH) to support research that has not been funded by the National Institutes of Health (NIH) due to budget cuts.

By Bill Snyder
Abstract translucent golden-brown organic form with looping ring-like shapes and red accents, isolated against a black background.
July 17, 2013

Probing roles of a cell death protein

Vanderbilt researchers have discovered new roles for a protein involved in cell death processes that are activated to prevent tumor-causing DNA mutations.

By Leigh MacMillan
Illustration of red blood cells and several white blood cells suspended in a red bloodstream.
October 25, 2012

Bid protein guards blood cells against stress

A protein normally known to promote cell death found to encourage survival of blood forming cells.

By Vanderbilt Health News